Matthew P. Goetz, MD, discusses the next steps for evaluating treatment with lasofoxifene.
Matthew Goetz, MD
Articles by Matthew Goetz, MD
Matthew P. Goetz, MD, discusses the background of the ELAINE-1 study examining lasofoxifene in patients with estrogen receptor-positive, HER2-negative metastatic breast cancer harboring estrogen receptor 1 mutations.
Matthew P. Goetz, MD, discusses recent data on estrogen receptor mutations in patients with breast cancer.
Matthew Goetz, MD, professor of oncology and pharmacology, Mayo Clinic, discusses a secondary analysis of the MONARCH 1 and MONARCH 2 clinical trials in breast cancer.
